Journal of Ovarian Research
|
Viewing options:Associated material:Related literature:- Articles citing this article
- Other articles by authors
- Related articles/pages
Tools:Post to:
|
  ReviewRole of CA125 in predicting ovarian cancer survival - a review of the epidemiological literatureDigant Gupta  and Christopher G Lis  Cancer Treatment Centers of America® at Midwestern Regional Medical Center, Zion, IL, USA  author email corresponding author email
Journal of Ovarian Research 2009,
2:13doi:10.1186/1757-2215-2-13
|
| Published: |
9 October 2009 |
Abstract
CA125 is the gold standard tumor marker in ovarian cancer. Serum level of CA125 is used to monitor response to chemotherapy, relapse, and disease progression in ovarian cancer patients. Thus, it is reasonable to investigate whether CA125 may have utility as a prognostic indicator as well in ovarian cancer. A large number of epidemiological studies have been carried out to this effect. This review summarizes all available epidemiological literature on the association between CA125 levels and survival in ovarian cancer. To place these studies in context, we provide some background information on CA125 and its role in ovarian cancer. | 
on Google Scholar
